Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000627332 | SCV000748324 | pathogenic | not provided | 2022-02-08 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 34423300) |
Revvity Omics, |
RCV001421034 | SCV002016403 | pathogenic | Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome | 2023-04-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000627332 | SCV002217974 | pathogenic | not provided | 2024-10-26 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg782*) in the LAMA1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LAMA1 are known to be pathogenic (PMID: 25105227, 26932191). This variant is present in population databases (rs374851540, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with clinical features of LAMA1-related conditions (PMID: 34423300). ClinVar contains an entry for this variant (Variation ID: 523859). For these reasons, this variant has been classified as Pathogenic. |
Sayer Lab, |
RCV001421034 | SCV001623457 | pathogenic | Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome | 2021-05-21 | no assertion criteria provided | clinical testing |